Chimeric Antigen Receptor Delivery Approaches in the Era of Regulatory-Approved T-cell Products for Cancer Immunotherapy

Abstract

This article does not have an abstract.

Description

Keywords

Citation

URI

Endorsement

Review

Supplemented By

Referenced By